My #1 Pre IPO Trade for 2025 – NAME and TICKER

One tiny company... Could quickly become "the next SpaceX." It plans to go public on the NASDAQ. And today you can buy Pre-IPO shares for less than $4.00. Get urgent details inside this free report...

Jesse Geiger Biography and Net Worth

CFO of Medpace

Jesse J. Geiger joined Medpace in October 2007 as Corporate Controller, and he was appointed Chief Financial Officer in March 2011. Mr. Geiger became Chief Operating Officer, Laboratory Operations in November 2014. Mr. Geiger was appointed to the position of President on August 1, 2021. Prior to joining Medpace, Mr. Geiger worked for SENCORP from 2004 to 2007 as the Corporate Controller and Manager of Financial Planning and Analysis. Prior to SENCORP, Mr. Geiger served as the Director of Capital Markets for Cincinnati Bell from 2002 to 2004. Mr. Geiger started his career in the audit practice at Arthur Andersen LLP. Mr. Geiger has served as a director for several private companies, including as a director of LIB Therapeutics, LLC since 2015 and as a director of CinRx Pharma, LLC since 2015. Mr. Geiger received his Bachelor of Business Administration in Accounting from the University of Cincinnati and is a Certified Public Accountant.

What is Jesse J. Geiger's net worth?: The estimated net worth of Jesse J. Geiger is at least $3.06 million as of April 14th, 2021. Mr. Geiger owns 9,382 shares of Medpace stock worth more than $3,059,376 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Geiger may own. Additionally, Mr. Geiger receives a salary of $945,080.00 as CFO at Medpace. Learn More about Jesse J. Geiger's net worth.
How old is Jesse J. Geiger?: Mr. Geiger is currently 50 years old. There are 5 older executives and no younger executives at Medpace. The oldest executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who is 68 years old. Learn More on Jesse J. Geiger's age.
What is Jesse J. Geiger's salary?: As the CFO of Medpace Holdings, Inc., Mr. Geiger earns $945,080.00 per year. There are 2 executives that earn more than Mr. Geiger. The highest earning executive at Medpace is Dr. August James Troendle M.D., Chairman & CEO, who commands a salary of $1,650,000.00 per year. Learn More on Jesse J. Geiger's salary.
How do I contact Jesse J. Geiger?: The corporate mailing address for Mr. Geiger and other Medpace executives is 5375 MEDPACE WAY, CINCINNATI OH, 45227. Medpace can also be reached via phone at (513) 579-9911 and via email at [email protected]. Learn More on Jesse J. Geiger's contact information.
Has Jesse J. Geiger been buying or selling shares of Medpace?: Jesse J. Geiger has not been actively trading shares of Medpace during the last quarter. Most recently, Jesse J. Geiger sold 3,000 shares of the business's stock in a transaction on Wednesday, April 14th. The shares were sold at an average price of $180.00, for a transaction totalling $540,000.00. Following the completion of the sale, the chief financial officer now directly owns 9,382 shares of the company's stock, valued at $1,688,760. Learn More on Jesse J. Geiger's trading history.
Who are Medpace's active insiders?: Medpace's insider roster includes Kevin Brady (CFO), Susan Burwig (VP), Stephen Ewald (General Counsel), Jesse Geiger (CFO), Ashley Keating (Director), Tom King (Director), Robert Kraft (Director), and August Troendle (CEO). Learn More on Medpace's active insiders.
Are insiders buying or selling shares of Medpace?: In the last twelve months, insiders at the sold shares 18 times. They sold a total of 354,352 shares worth more than $125,958,649.42. The most recent insider tranaction occured on May, 28th when CEO August J Troendle sold 5,695 shares worth more than $2,252,315.55. Insiders at Medpace own 20.3% of the company. Learn More about insider trades at Medpace.
Information on this page was last updated on 5/28/2024.

Jesse J. Geiger Insider Trading History at Medpace

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/14/2021	Sell	3,000	$180.00	$540,000.00	9,382
2/10/2021	Sell	4,000	$160.00	$640,000.00	10,382
9/1/2020	Sell	3,110	$130.00	$404,300.00	10,082
12/19/2019	Sell	14,400	$82.00	$1,180,800.00	16,948
10/14/2019	Sell	7,200	$78.03	$561,816.00	40,948
4/1/2019	Sell	25,037	$60.00	$1,502,220.00	25,037
3/29/2019	Sell	12,000	$58.20	$698,400.00	25,037
8/2/2018	Sell	7,407	$60.15	$445,531.05

Jesse J. Geiger Buying and Selling Activity at Medpace

Medpace Company Overview

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Today's Range

Now: $326.09

$313.62

$327.89

50 Day Range

MA: $340.48

$308.93

$369.18

2 Week Range

Now: $326.09

$268.80

$459.77

Volume

375,972 shs

Average Volume

402,318 shs

Market Capitalization

$10.13 billion

P/E Ratio

28.55

Dividend Yield

N/A

Beta

1.37

My #1 Pre IPO Trade for 2025 – NAME and TICKER

From Wyatt Investment Research | Ad

The Next SpaceX Pre-IPO

Jesse Geiger Biography and Net Worth

What is Jesse J. Geiger's net worth?

How old is Jesse J. Geiger?

What is Jesse J. Geiger's salary?

How do I contact Jesse J. Geiger?

Has Jesse J. Geiger been buying or selling shares of Medpace?

Who are Medpace's active insiders?

Are insiders buying or selling shares of Medpace?